FAMILIAL COMBINED HYPERLIPIDEMIA: CURRENT KNOWLEDGE, PERSPECTIVES, AND CONTROVERSIES.
Bello-Chavolla OY, Kuri-García A, Ríos-Ríos M, Vargas-Vázquez A, Cortés-Arroyo JE, Tapia-González G, Cruz-Bautista I, Aguilar-Salinas CA.
Rev Invest Clin. 2018;70(5):224-236. doi: 10.24875/RIC.18002575.
Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia.
Trinder M, Vikulova D, Pimstone S, Mancini GBJ, Brunham LR.
Atherosclerosis. 2022 Jan;340:35-43. doi: 10.1016/j.atherosclerosis.2021.11.032. Epub 2021 Dec 6.
A novel mouse model of familial combined hyperlipidemia and atherosclerosis.
Chen MJ, Xu YT, Sun L, Wang ZH, Little PJ, Wang L, Xian XD, Weng JP, Xu SW.
Acta Pharmacol Sin. 2024 Jun;45(6):1316-1320. doi: 10.1038/s41401-024-01241-8. Epub 2024 Mar 8.
Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategies.
Taghizadeh E, Esfehani RJ, Sahebkar A, Parizadeh SM, Rostami D, Mirinezhad M, Poursheikhani A, Mobarhan MG, Pasdar A.
IUBMB Life. 2019 Sep;71(9):1221-1229. doi: 10.1002/iub.2073. Epub 2019 Jul 4.
Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia.
Gill PK, Dron JS, Berberich AJ, Wang J, McIntyre AD, Cao H, Hegele RA.
J Clin Lipidol. 2021 Jan-Feb;15(1):79-87. doi: 10.1016/j.jacl.2020.11.006. Epub 2020 Nov 24.
Familial combined hyperlipidaemia/polygenic mixed hyperlipidaemia.
Pedro-Botet J, Climent E, Gabarró N, Millán J.
Clin Investig Arterioscler. 2021 May;33 Suppl 2:43-49. doi: 10.1016/j.arteri.2020.12.013.
Genetics of Familial Combined Hyperlipidemia (FCHL) Disorder: An Update.
Taghizadeh E, Farahani N, Mardani R, Taheri F, Taghizadeh H, Gheibihayat SM.
Biochem Genet. 2022 Apr;60(2):453-481. doi: 10.1007/s10528-021-10130-2. Epub 2021 Sep 3.
Familial Combined Hyperlipidemia: Myth or Reality?
Brouwers MCGJ, Klop B, Ribalta J, Castro Cabezas M.
Curr Atheroscler Rep. 2025 Apr 1;27(1):45. doi: 10.1007/s11883-025-01289-9.
Familial Hypercholesterolemia, Familial Combined Hyperlipidemia, and Elevated Lipoprotein(a) in Patients With Premature Coronary Artery Disease.
Vikulova DN, Trinder M, Mancini GBJ, Pimstone SN, Brunham LR.
Can J Cardiol. 2021 Nov;37(11):1733-1742. doi: 10.1016/j.cjca.2021.08.012. Epub 2021 Aug 26.
Familial combined hyperlipidemia is a polygenic trait.
Gill PK, Hegele RA.
Curr Opin Lipidol. 2022 Apr 1;33(2):126-132. doi: 10.1097/MOL.0000000000000796.
